Stay updated on BOTOX in IC/BPS: Disease Activity & Adverse Events Clinical Trial
Sign up to get notified when there's something new on the BOTOX in IC/BPS: Disease Activity & Adverse Events Clinical Trial page.

Latest updates to the BOTOX in IC/BPS: Disease Activity & Adverse Events Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check32 days agoNo Change Detected
- Check39 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check46 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
- Check60 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check67 days agoChange DetectedThe study of BOTOX injections for adult female participants with Interstitial Cystitis/Bladder Pain Syndrome has been updated with new details, including a change in the sponsor from Allergan to AbbVie and a revised timeline, while the previous version has been removed.SummaryDifference2%
- Check96 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
Stay in the know with updates to BOTOX in IC/BPS: Disease Activity & Adverse Events Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BOTOX in IC/BPS: Disease Activity & Adverse Events Clinical Trial page.